Contemporary Pediatrics

Contemporary Pediatrics Expert Clinical Advice for Today's Pediatrician

New research highlights how differences in state laws may be linked to changing trends in pediatric firearm mortality ac...
06/13/2025

New research highlights how differences in state laws may be linked to changing trends in pediatric firearm mortality across the United States.

Full details: https://hubs.li/Q03rM3dW0

According to recent research published in Human Reproduction, childhood adversity may raise risk, with exposure to vio...
06/11/2025

According to recent research published in Human Reproduction, childhood adversity may raise risk, with exposure to violence linked to a 2-fold increase, observed in Swedish study of 1.3 million women.

Study details: https://hubs.li/Q03rLWjX0

In this video interview, Aaron Milstone, MD of Johns Hopkins Children's Center discusses prevalence and impact of invasi...
06/11/2025

In this video interview, Aaron Milstone, MD of Johns Hopkins Children's Center discusses prevalence and impact of invasive Staphylococcus aureus, with recent research highlighting a greater impact among very low birth weight .

Watch the discussion on the Contemporary Pediatrics website now: https://hubs.li/Q03rHgjL0

According to recent data presented by Regeneron and Sanofi, dupilumab demonstrated positive outcomes in a study populati...
06/11/2025

According to recent data presented by Regeneron and Sanofi, dupilumab demonstrated positive outcomes in a study population of adults and adolescents aged 12 years and older with moderate-to-severe and skin of color.

Improved disease severity, itch, and a reduced post-inflammatory hyperpigmentation were observed.

Andrew Alexis, MD, MPH, of Weill Cornell Medical College Dermatology stated these data offer a deeper insight to the understanding of AD in an underserved population.

Read more, including specific data points here: https://hubs.li/Q03rH3zZ0

06/10/2025

Today, Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) announced that the first child has been enrolled in the phase 2 INTEGUMENT-INFANT, which will evaluate the safety and tolerability of the topical cream 0.05% to treat among an population 3 months to less than 2 years of age.

More information and other approved indications of roflumilast: https://hubs.li/Q03ry-nX0

Watch as Octavio Ramilo, MD, of St. Jude Children's Research Hospital, breaks down the recent approval of Merck's mono...
06/10/2025

Watch as Octavio Ramilo, MD, of St. Jude Children's Research Hospital, breaks down the recent approval of Merck's monoclonal antibody clesrovimab to prevent disease in infants.

Ramilo is also a clinical investigator of the CLEVER and SMART trials, for which approval was based.

Watch: https://hubs.li/Q03rvWHc0

BREAKING NEWS: The FDA has approved Merck's monoclonal antibody to protect infants from respiratory syncytial virus (R...
06/09/2025

BREAKING NEWS:

The FDA has approved Merck's monoclonal antibody to protect infants from respiratory syncytial virus (RSV) disease during their first season.

Full approval details and study data: https://hubs.li/Q03rnpZb0

Today, Ascendis Pharma announced positive, interim data from the phase 2 COACH trial, evaluating evaluating once-weekly ...
06/09/2025

Today, Ascendis Pharma announced positive, interim data from the phase 2 COACH trial, evaluating evaluating once-weekly navepegritide (TransCon CNP) and once-weekly lonapegsomatropin (TransCon hGH) combination therapy for children with .

Results demonstrated growth and proportionality improvements. Aimee Shu, MD, CMO of Ascendis and of Stanford University School of Medicine comments below.

View full details: https://hubs.li/Q03rk2Ms0

Welcome to a new week! Catch up on anything you may have missed from Contemporary Pediatrics with our weekly review arti...
06/09/2025

Welcome to a new week! Catch up on anything you may have missed from Contemporary Pediatrics with our weekly review article.

Read more: https://hubs.li/Q03rdPNd0

The first week of June has come and gone! If you are feeling behind on news, view our quick recap from May, which featur...
06/08/2025

The first week of June has come and gone! If you are feeling behind on news, view our quick recap from May, which features our top headlines from the month.

Read more: https://hubs.li/Q03qML1V0

ICYMI: According to an announcement from SoundHealth, the expanded approval makes the FDA De Novo authorized, AI-enabled...
06/07/2025

ICYMI:

According to an announcement from SoundHealth, the expanded approval makes the FDA De Novo authorized, AI-enabled device the first FDA-approved, drug-free solution for nasal congestion and allergies.

Details:https://hubs.li/Q03qMtgL0

ICYMI: The federal agency has accepted Ascendis Pharma's NDA for navepegritide (TransCon CNP) to treat children with . ...
06/06/2025

ICYMI:

The federal agency has accepted Ascendis Pharma's NDA for navepegritide (TransCon CNP) to treat children with .

Read here for the PDUFA date, and additional details: https://hubs.li/Q03qSs8B0

Address

25115 Country Club Boulevard
North Olmsted, OH
44070

Website

Alerts

Be the first to know and let us send you an email when Contemporary Pediatrics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Contemporary Pediatrics:

Shortcuts

Share

Category